Covid patient finally cleared of virus after 411 days of testing positive

A CORONAVIRUS patient who tested positive for 411 days finally got rid of the virus.

Doctors hailed a cocktail of drugs used to treat the 59-year-old.

In this most recent case, the man first tested positive in December 2020


In this most recent case, the man first tested positive in December 2020Credit: Reuters

Writing in the journal Clinical Infectious Diseases, British doctors said the patient had struggled to clear an early variant of the virus.

The patient had a weakened immune system after undergoing a kidney transplant.

Doctors from Guy’s and St Thomas’ NHS Foundation Trust, London, and King’s College London said the man would be one of the oldest patients with persistent Covid infection.

A former patient treated by the same team tested positive for Covid for 505 days but later died.

Urgent warning as 'millions' of Britons risk becoming a silent killer due to Covid delays
Covid deaths jump 21% in a week as cases 'stabilize and last wave peaks'

And in February, another man explained how he self-isolated for 14 months, after testing positive for the virus for 78 consecutive days.

In this most recent case, the man had first tested positive in December 2020.

While his symptoms subsided, he continued to test positive intermittently until January 2020.

In order to help treat the patient, doctors detected the man’s ongoing infection by analyzing the genetics of the virus strain he was carrying.

He was then administered a cocktail of neutralizing antibodies (Regeneron) known to be effective against early variants of the coronavirus, which finally allowed his body to get rid of Covid.

It is highly likely that the patient had the original Alpha strain of the virus.

The variant currently in circulation in the UK, Omicron, is milder than its predecessors and many people have now received a vaccine which also helps protect against serious illnesses.

But due to the changing nature of the virus, experts have said these antibody treatments are now largely ineffective.

Dr Luke Snell, from Guy’s & St Thomas’, said: ‘Some new variants of the virus are resistant to all antibody treatments available in the UK and Europe.

“Some people with weakened immune systems are still at risk of serious illness and persistent infection. We are still working to understand the best way to protect and deal with them.

The ineffectiveness of these drugs had previously been cited as a reason why thousands of vulnerable Britons were unable to get their hands on the ‘lifesaving’ drug Evusheld.

Evusheld will give vulnerable people some protection against the virus.

It is made by AstraZeneca and was approved by the medicines regulator in March.

Since then, it has also become available in 30 other countries.

Despite its widespread use, the UK government has said it will not buy any more doses until it has more data.

This is due to concerns about its effectiveness against the Omicron variant currently circulating in the UK.

The Department of Health has previously said it is urgently considering commissioning a clinical trial for the drug.

Leave a Comment